Home

Immunic, Inc. - Common Stock (IMUX)

1.0100
-0.2700 (-21.09%)
NASDAQ · Last Trade: Apr 30th, 3:26 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · April 30, 2025
Wednesday's session: gap up and gap down stockschartmill.com
The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via Chartmill · April 30, 2025
These stocks that are showing activity before the opening bell on Wednesday.chartmill.com
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · April 30, 2025
IMUX Stock Earnings: Immunic Misses EPS for Q1 2024investorplace.com
IMUX stock results show that Immunic missed analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 8, 2024
Immunic's Earnings Outlookbenzinga.com
Via Benzinga · February 21, 2024
Immunic: Q3 Earnings Insightsbenzinga.com
Via Benzinga · November 14, 2023
A Preview Of Immunic's Earningsbenzinga.com
Via Benzinga · November 13, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · April 30, 2025
Immunic Stock Draws Investor Attention On $5.1M Registered Direct Offering: Retail’s On Wait-And-Watch Modestocktwits.com
Immunic intends to use the net proceeds from the proposed offering to fund its clinical trials and operations and for other general corporate purposes.
Via Stocktwits · April 9, 2025
This Yelp Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Mondaybenzinga.com
Via Benzinga · September 16, 2024
Peek Behind the Curtain: 7 Penny Stocks With Heavy Insider Buyinginvestorplace.com
While speculative ideas are treacherous, you can possibly reduce your blood pressure with these penny stocks with insider buying.
Via InvestorPlace · May 23, 2024
Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
Via News Direct · May 20, 2024
Immunic "super excited" about latest PMS trial data
--News Direct--
Via News Direct · October 11, 2023
Immunic chief medical officer discusses promising treatments to mark World IBD Day
Immunic chief medical officer discusses promising treatments to mark World IBD Day
Via News Direct · May 17, 2024
Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day
Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day
Via News Direct · May 16, 2024
Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones
Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones
Via News Direct · May 9, 2024
Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
Via News Direct · May 1, 2024
Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
--News Direct--
Via News Direct · March 21, 2024
Immunic And 2 Other Stocks Under $2 Insiders Are Buyingbenzinga.com
The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · February 29, 2024
What's Going On With Immunic Stock?benzinga.com
Immunic, Inc. (NASDAQ: IMUX) shares are roughly flat following strength early Friday after the company announced a three-tranche private placement of up to $240 million.
Via Benzinga · January 5, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · January 5, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Fridayinvestorplace.com
Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning!
Via InvestorPlace · January 5, 2024
Immunic CSO hails "great" progress with MS program
--News Direct--
Via News Direct · October 24, 2023
Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessionbenzinga.com
Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday.
Via Benzinga · October 10, 2023
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 10, 2023